Kardiolytics Inc.
The most effective and safe procedures for coronary vessel analytics
About
The Virtual Cardiac Stress Test (VCAST) is a patented, AI-based medical system developed for non-invasive, clinical quantitative and qualitative analysis of CT-scan data, to assess the hemodynamic significance of coronary artery atherosclerotic stenosis. The Kardiolytics cardiac test is rapid, inexpensive and entirely noninvasive. It provides personalized, color-coded, 3D modeling of the coronary arteries combined with detailed, functional diagnostic information regarding blood flow. This includes computed quantities of blood, pressure, and velocity and is designed to assist the physician both in completing the diagnosis and designing the treatment plan for coronary artery disease. The test provides information usually obtained only by the highly invasive FFR test (that involves inserting a pressure wire into coronary arteries). All data that are required for VCAST come from a widely available and inexpensive CT-scan imaging that is conducted by a technician and not a doctor and the results can be forwarded to a doctor remotely. It is independent of imaging equipment, imaging protocols, and equipment vendors.
Product
- Value proposition
- AI-driven analysis of CT scans to noninvasively assess coronary artery disease and hemodynamic significance, providing diagnostic and planning information that previously required invasive procedures
- Target customers
- Cardiology clinics, hospitals, radiology groups, healthcare providers
Founders
- Paul Lewicki — Co-Founder
- Kris Siemionow — Co-Founder
Categories
Products
Key features
Technologies
Integrations
Target conditions
Care settings
News
- VCAST - Medicalgorithmics · 2025-07-24T11:37:43.000Z
- VCAST technology with European patent – a breakthrough in AI-based cardiac imaging - Medicalgorithmics · 2025-07-11T06:40:55.000Z
- Non-Invasive and Rapid Coronary Artery Disease Diagnosis with VCAST: Medicalgorithmics Prepares for Commercialization of New AI Technology - Medicalgorithmics · 2024-07-29T14:46:06.000Z
- Kardiolytics z przełomem w obrazowaniu serca. Europejski patent · 2025-07-11T07:23:04.000Z
- Medicalgorithmics S A : VCAST technology with European patent – a breakthrough in AI-based cardiac imaging | MarketScreener India · 2025-07-11T06:48:10.000Z
- Kardiolytics z patentem w UE. VCAST to nowe możliwości w diagnostyce serca | Alert Medyczny · 2025-07-11T09:35:22.000Z
Browse similar startups
Related startups
- KNOWN — chicago, IL
- Mercurial AI — Chicago, IL
- Mothergood Health — South Barrington, IL
- MyMenopauseRx — Wheaton, IL
- Nutrisense — Chicago, IL
- Oncology of NorthShore — Chicago, IL
- Louisville Cardiology Med Grp — Louisville, KY
- NASSER CARDIOLOGY, P.A. — The Woodlands, TX
- Pacific Pediatric Cardiology — Victorville, CA
- St Luke Heart Institute — Brooksville, FL
- SWICFT Cardiology — Naples, FL
- Toledo Cardiology Consultants — Oregon, OR
Profile updated Jul 29, 2026. Sources: kardiolytics.com
